JPRN-UMIN000003286
Recruiting
未知
Anti-viral therapy for recurrent hepatitis C after living donor liver transplantation - Anti-viral therapy for hepatitis C after liver transplantation
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Kyoto University
- Enrollment
- 150
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Retreatment of hepatitis C non-responsive to Interferon: a placebo controlled randomised trial of Ribavirin monotherapy versus combination therapy with Ribavirin and Interferon in 121 patients in the BeneluxChronic hepatitis CInfections and InfestationsHepatitisISRCTN53821378Schering Plough International (USA)117
Active, not recruiting
Not Applicable
Tailoring antiviral therapy of chronic hepatitis C to the single patient standard therapy versus treatment guided by a physic-mathematical model of the dynamics of Hepatitis C Virus infection. - Tailoring antiviral therapy by HCV dynamicsChronic Hepatitis C with or without cirrhosisMedDRA version: 6.1Level: PTClassification code 10019744EUCTR2006-002483-26-ITAZIENDA OSPEDALIERA PISANA240
Active, not recruiting
Phase 1
Direct acting antiviral therapy of hepatitis C in Denmark: treatment response, adverse events and resistance associated variantsPatients with chronic hepatitis CMedDRA version: 19.1Level: LLTClassification code 10074391Term: Chronic hepatitis C virus genotype 1System Organ Class: 100000004862Therapeutic area: Diseases [C] - Virus Diseases [C02]EUCTR2015-001956-31-DKDepartment of Infectious Diseases, Copenhagen University Hospital, Hvidovre.111
Completed
Phase 2
A pilot phase II open-label study of oglufanide disodium in patients with chronic hepatitis CChronic hepatitis CInfection - Other infectious diseasesACTRN12607000418471Implicit Bioscience Pty Ltd17
Completed
Not Applicable
Spirulina Platensis in the Treatment of Chronic Hepatitis C Virus (HCV) InfectioACTRN12610000958088Abbass Helmy Charity60